Headlines

Excerpted from daily Google News Alerts. Stories are
in date order with most recent stories at the top.

GPC
Takes a Pit Stop

Motley
Fool – USA

The company was trying to get Satraplatin approved to treat
hormone-refractory prostate cancer in patients
whose prior chemotherapy has failed.

See all stories on this topic

Pressure
for Provenge Approval

BusinessWeek
- USA

A prostate cancer patient group files suit,
demanding an FDA green light of Dendreon’s vaccine. Investors are on
board, too by Catherine Arnst A group

See all stories on this topic

Good
news for prostate
cancer
patients

TopCancerNews.com
- Dallas,TX,USA

There’s good news for prostate cancer patients
who’ve had the disease spread to other parts of the body — a new
treatments, currently being tried out on

See all stories on this topic

Clarient
and Health Discovery Corporation Initiate Alliance with

CNNMoney.com
- USA

Under the terms of the agreement, Clarient obtained an exclusive
license to HDC’s prostate cancer marker and plans
to immediately initiate the

See all stories on this topic

OncoGenex
and Isis Report Encouraging Interim Phase II Data in

CNNMoney.com
- USA

“Docetaxel is the only agent to have demonstrated a survival benefit in
patients with hormone refractory prostate cancer,”
said Cindy Jacobs, MD,

See all stories on this topic

Comments are closed.